SENS 2 Deadlines, June 15th

The early registration and abstract submission deadlines for the second conference on Strategies for Engineered Negligible Senescence (SENS 2) are on June 15th, 2005. "The purpose of the SENS conference series, like all the SENS initiatives (such as the journal Rejuvenation Research and the Methuselah Mouse Prize), is to expedite the development of truly effective therapies to postpone and treat human aging by tackling it as an engineering problem: not seeking elusive and probably illusory magic bullets, but instead enumerating the accumulating molecular and cellular changes that eventually kill us and identifying ways to repair - reverse - those changes, rather than merely to slow down their further accumulation. This year's SENS Lecture, provisionally entitled 'Stem cells, SCNT and the rejuvenation imperative', will be given by Dr. Michael West, CEO of Advanced Cell Technology."



Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.